258 related articles for article (PubMed ID: 19284379)
1. Intracranial ependymoma: factors affecting outcome.
Massimino M; Buttarelli FR; Antonelli M; Gandola L; Modena P; Giangaspero F
Future Oncol; 2009 Mar; 5(2):207-16. PubMed ID: 19284379
[TBL] [Abstract][Full Text] [Related]
2. Intracranial ependymomas of childhood: current management strategies.
Smyth MD; Horn BN; Russo C; Berger MS
Pediatr Neurosurg; 2000 Sep; 33(3):138-50. PubMed ID: 11096361
[TBL] [Abstract][Full Text] [Related]
3. Advances in Management of Pediatric Ependymomas.
Lin FY; Chintagumpala M
Curr Oncol Rep; 2015 Oct; 17(10):47. PubMed ID: 26369328
[TBL] [Abstract][Full Text] [Related]
4. Ependymal tumors in childhood.
Agaoglu FY; Ayan I; Dizdar Y; Kebudi R; Gorgun O; Darendeliler E
Pediatr Blood Cancer; 2005 Sep; 45(3):298-303. PubMed ID: 15770637
[TBL] [Abstract][Full Text] [Related]
5. [Intracranial ependymomas. Experience with 86 cases].
Lejeune JP; Dhellemmes P; Dupard T; Combelles G; Delandsheer JM
Neurochirurgie; 1987; 33(2):118-23. PubMed ID: 3600940
[TBL] [Abstract][Full Text] [Related]
6. Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma.
Mendrzyk F; Korshunov A; Benner A; Toedt G; Pfister S; Radlwimmer B; Lichter P
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2070-9. PubMed ID: 16609018
[TBL] [Abstract][Full Text] [Related]
7. The histologic grade is a main prognostic factor for patients with intracranial ependymomas treated in the microneurosurgical era: an analysis of 258 patients.
Korshunov A; Golanov A; Sycheva R; Timirgaz V
Cancer; 2004 Mar; 100(6):1230-7. PubMed ID: 15022291
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic results of eight patients with intracranial ependymomas].
Sasajima T; Takahashi M; Kinouchi H; Suzuki A; Mizoi K
No To Shinkei; 2003 Mar; 55(3):233-40. PubMed ID: 12728504
[TBL] [Abstract][Full Text] [Related]
9. Genetic expression profiles of adult and pediatric ependymomas: molecular pathways, prognostic indicators, and therapeutic targets.
Nagasawa DT; Trang A; Choy W; Spasic M; Yew A; Zarinkhou G; Garcia HM; Yang I
Clin Neurol Neurosurg; 2013 Apr; 115(4):388-99. PubMed ID: 23374238
[TBL] [Abstract][Full Text] [Related]
10. [Brain tumors in infants and children--factors affecting prognosis. (Part 1) Ependymoma (author's transl)].
Oi S; Raimondi AJ
No Shinkei Geka; 1980 Nov; 8(11):1049-55. PubMed ID: 7453936
[TBL] [Abstract][Full Text] [Related]
11. Nucleolin overexpression is associated with an unfavorable outcome for ependymoma: a multifactorial analysis of 176 patients.
Chen C; Chen L; Yao Y; Qin Z; Chen H
J Neurooncol; 2016 Mar; 127(1):43-52. PubMed ID: 26615563
[TBL] [Abstract][Full Text] [Related]
12. Pediatric intracranial ependymomas: prognostic relevance of histological, immunohistochemical, and flow cytometric factors.
Zamecnik J; Snuderl M; Eckschlager T; Chanova M; Hladikova M; Tichy M; Kodet R
Mod Pathol; 2003 Oct; 16(10):980-91. PubMed ID: 14559980
[TBL] [Abstract][Full Text] [Related]
13. Ependymoma gene expression profiles associated with histological subtype, proliferation, and patient survival.
Lukashova-v Zangen I; Kneitz S; Monoranu CM; Rutkowski S; Hinkes B; Vince GH; Huang B; Roggendorf W
Acta Neuropathol; 2007 Mar; 113(3):325-37. PubMed ID: 17265049
[TBL] [Abstract][Full Text] [Related]
14. [Intracranial ependymomas in adult patients. Retrospective analysis of 121 cases from the multicentric French study].
Metellus P; Barrie M; Figarella-Branger D; Chinot O; Giorgi R; Jouvet A; Guyotat J
Neurochirurgie; 2007 Jun; 53(2-3 Pt 1):66-75. PubMed ID: 17475290
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors and treatment options for paediatric ependymomas.
Vaidya K; Smee R; Williams JR
J Clin Neurosci; 2012 Sep; 19(9):1228-35. PubMed ID: 22840355
[TBL] [Abstract][Full Text] [Related]
16. Treatment results in patients with intracranial ependymomas.
Boström A; Boström J; Hartmann W; Pietsch T; Feuss M; von Lehe M; Simon M
Cent Eur Neurosurg; 2011 Aug; 72(3):127-32. PubMed ID: 21630189
[TBL] [Abstract][Full Text] [Related]
17. Molecular staging of intracranial ependymoma in children and adults.
Korshunov A; Witt H; Hielscher T; Benner A; Remke M; Ryzhova M; Milde T; Bender S; Wittmann A; Schöttler A; Kulozik AE; Witt O; von Deimling A; Lichter P; Pfister S
J Clin Oncol; 2010 Jul; 28(19):3182-90. PubMed ID: 20516456
[TBL] [Abstract][Full Text] [Related]
18. A multicenter study of the prognosis and treatment of adult brain ependymal tumors.
Reni M; Brandes AA; Vavassori V; Cavallo G; Casagrande F; Vastola F; Magli A; Franzin A; Basso U; Villa E
Cancer; 2004 Mar; 100(6):1221-9. PubMed ID: 15022290
[TBL] [Abstract][Full Text] [Related]
19. Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical trial cohort analysis on behalf of the Children's Cancer Leukaemia Group (CCLG), Societe Francaise d'Oncologie Pediatrique (SFOP), and International Society for Pediatric Oncology (SIOP).
Kilday JP; Mitra B; Domerg C; Ward J; Andreiuolo F; Osteso-Ibanez T; Mauguen A; Varlet P; Le Deley MC; Lowe J; Ellison DW; Gilbertson RJ; Coyle B; Grill J; Grundy RG
Clin Cancer Res; 2012 Apr; 18(7):2001-11. PubMed ID: 22338015
[TBL] [Abstract][Full Text] [Related]
20. Infratentorial ependymomas: prognostic factors and outcome analysis in a multi-center retrospective series of 106 adult patients.
Guyotat J; Metellus P; Giorgi R; Barrie M; Jouvet A; Fevre-Montange M; Chinot O; Durand A; Figarella-Branger D
Acta Neurochir (Wien); 2009 Aug; 151(8):947-60. PubMed ID: 19499166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
